Cornerstone Capital Management Holdings’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Cornerstone Capital Management Holdings's ABBV Position: Q4 2017 in Review
Cornerstone Capital Management Holdings reduced its AbbVie (ABBV) stake by 8.8% in Q4 2017, selling an estimated $7.3M and leaving 803,096 shares worth $77.7M. The position accounts for 0.54% of the portfolio, ranked #28.
Cornerstone Capital Management Holdings first reported a position in ABBV in Q2 2013 and has held it in 19 quarters since. The position peaked at $78.2M in Q3 2017. 2,000 funds tracked by Wall St. Rank hold ABBV as of Q4 2017.
- Cornerstone Capital Management Holdings held 803,096 shares of AbbVie worth $77.7M as of Q4 2017.
- Cornerstone Capital Management Holdings sold 77,457 AbbVie shares in Q4 2017, an estimated $7.3M.
- AbbVie made up 0.54% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #28 holding.
- Cornerstone Capital Management Holdings first reported a position in AbbVie in Q2 2013 and has held it in 19 quarters since.
- Cornerstone Capital Management Holdings's AbbVie position peaked at $78.2M in Q3 2017.
- 2,000 funds tracked by Wall St. Rank held AbbVie as of Q4 2017.
Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.